232 related articles for article (PubMed ID: 11932257)
1. Presence of cathepsin B in the human pancreatic secretory pathway and its role in trypsinogen activation during hereditary pancreatitis.
Kukor Z; Mayerle J; Krüger B; Tóth M; Steed PM; Halangk W; Lerch MM; Sahin-Tóth M
J Biol Chem; 2002 Jun; 277(24):21389-96. PubMed ID: 11932257
[TBL] [Abstract][Full Text] [Related]
2. Missorting of cathepsin B into the secretory compartment of CI-MPR/IGFII-deficient mice does not induce spontaneous trypsinogen activation but leads to enhanced trypsin activity during experimental pancreatitis--without affecting disease severity.
Meister T; Niehues R; Hahn D; Domschke W; Sendler M; Lerch MM; Schnekenburger J
J Physiol Pharmacol; 2010 Oct; 61(5):565-75. PubMed ID: 21081800
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro studies on native and recombinant human cationic trypsins. Cathepsin B is a possible pathological activator of trypsinogen in pancreatitis.
Szilágyi L; Kénesi E; Katona G; Kaslik G; Juhász G; Gráf L
J Biol Chem; 2001 Jul; 276(27):24574-80. PubMed ID: 11312265
[TBL] [Abstract][Full Text] [Related]
4. Cathepsin B cleavage of the trypsinogen activation peptide.
Teich N; Bödeker H; Keim V
BMC Gastroenterol; 2002 Jun; 2():16. PubMed ID: 12102727
[TBL] [Abstract][Full Text] [Related]
5. Interaction between trypsinogen isoforms in genetically determined pancreatitis: mutation E79K in cationic trypsin (PRSS1) causes increased transactivation of anionic trypsinogen (PRSS2).
Teich N; Le Maréchal C; Kukor Z; Caca K; Witzigmann H; Chen JM; Tóth M; Mössner J; Keim V; Férec C; Sahin-Tóth M
Hum Mutat; 2004 Jan; 23(1):22-31. PubMed ID: 14695529
[TBL] [Abstract][Full Text] [Related]
6. Cathepsin L inactivates human trypsinogen, whereas cathepsin L-deletion reduces the severity of pancreatitis in mice.
Wartmann T; Mayerle J; Kähne T; Sahin-Tóth M; Ruthenbürger M; Matthias R; Kruse A; Reinheckel T; Peters C; Weiss FU; Sendler M; Lippert H; Schulz HU; Aghdassi A; Dummer A; Teller S; Halangk W; Lerch MM
Gastroenterology; 2010 Feb; 138(2):726-37. PubMed ID: 19900452
[TBL] [Abstract][Full Text] [Related]
7. Increased activation of hereditary pancreatitis-associated human cationic trypsinogen mutants in presence of chymotrypsin C.
Szabó A; Sahin-Tóth M
J Biol Chem; 2012 Jun; 287(24):20701-10. PubMed ID: 22539344
[TBL] [Abstract][Full Text] [Related]
8. The role of cysteine proteases in intracellular pancreatic serine protease activation.
Lerch MM; Halangk W; Krüger B
Adv Exp Med Biol; 2000; 477():403-11. PubMed ID: 10849766
[TBL] [Abstract][Full Text] [Related]
9. Hereditary pancreatitis caused by a novel PRSS1 mutation (Arg-122 --> Cys) that alters autoactivation and autodegradation of cationic trypsinogen.
Simon P; Weiss FU; Sahin-Toth M; Parry M; Nayler O; Lenfers B; Schnekenburger J; Mayerle J; Domschke W; Lerch MM
J Biol Chem; 2002 Feb; 277(7):5404-10. PubMed ID: 11719509
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin B-Mediated Activation of Trypsinogen in Endocytosing Macrophages Increases Severity of Pancreatitis in Mice.
Sendler M; Weiss FU; Golchert J; Homuth G; van den Brandt C; Mahajan UM; Partecke LI; Döring P; Gukovsky I; Gukovskaya AS; Wagh PR; Lerch MM; Mayerle J
Gastroenterology; 2018 Feb; 154(3):704-718.e10. PubMed ID: 29079517
[TBL] [Abstract][Full Text] [Related]
11. Cathepsin B inhibition prevents trypsinogen activation and reduces pancreatitis severity.
Van Acker GJ; Saluja AK; Bhagat L; Singh VP; Song AM; Steer ML
Am J Physiol Gastrointest Liver Physiol; 2002 Sep; 283(3):G794-800. PubMed ID: 12181196
[TBL] [Abstract][Full Text] [Related]
12. Hereditary pancreatitis caused by mutation-induced misfolding of human cationic trypsinogen: a novel disease mechanism.
Kereszturi E; Szmola R; Kukor Z; Simon P; Weiss FU; Lerch MM; Sahin-Tóth M
Hum Mutat; 2009 Apr; 30(4):575-82. PubMed ID: 19191323
[TBL] [Abstract][Full Text] [Related]
13. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis.
Van Acker GJ; Weiss E; Steer ML; Perides G
Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1738-46. PubMed ID: 17332471
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin B activates human trypsinogen 1 but not proelastase 2 or procarboxypeptidase B.
Lindkvist B; Fajardo I; Pejler G; Borgström A
Pancreatology; 2006; 6(3):224-31. PubMed ID: 16534247
[TBL] [Abstract][Full Text] [Related]
15. Roles of Autophagy and Pancreatic Secretory Trypsin Inhibitor in Trypsinogen Activation in Acute Pancreatitis.
Hirota M; Ohmuraya M; Hashimoto D; Suyama K; Sugita H; Ogawa M
Pancreas; 2020 Apr; 49(4):493-497. PubMed ID: 32282761
[TBL] [Abstract][Full Text] [Related]
16. CaMKII/proteasome/cytosolic calcium/cathepsin B axis was present in tryspin activation induced by nicardipine.
Xiao J; Lin H; Liu B; Jin J
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31221819
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of a transgenic mouse expressing R122H human cationic trypsinogen.
Selig L; Sack U; Gaiser S; Klöppel G; Savkovic V; Mössner J; Keim V; Bödeker H
BMC Gastroenterol; 2006 Oct; 6():30. PubMed ID: 17069643
[TBL] [Abstract][Full Text] [Related]
18. Cerulein-induced in vitro activation of trypsinogen in rat pancreatic acini is mediated by cathepsin B.
Saluja AK; Donovan EA; Yamanaka K; Yamaguchi Y; Hofbauer B; Steer ML
Gastroenterology; 1997 Jul; 113(1):304-10. PubMed ID: 9207291
[TBL] [Abstract][Full Text] [Related]
19. Effect of short-termed pancreatic duct obstruction on the pancreatic subcellular organellar fragility and pancreatic lysosomal enzyme secretion in rabbits.
Hirano T; Manabe T
Scand J Clin Lab Invest; 1992 Oct; 52(6):523-35. PubMed ID: 1384108
[TBL] [Abstract][Full Text] [Related]
20. Role of cathepsin B in intracellular trypsinogen activation and the onset of acute pancreatitis.
Halangk W; Lerch MM; Brandt-Nedelev B; Roth W; Ruthenbuerger M; Reinheckel T; Domschke W; Lippert H; Peters C; Deussing J
J Clin Invest; 2000 Sep; 106(6):773-81. PubMed ID: 10995788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
